HAPTO Biotech (Israel) Overview

  • Founded
  • 2000
  • Status
  • Acquired/​Merged
  • Latest Deal Type
  • M&A

HAPTO Biotech (Israel) General Information


Provider of fibrinogen based products for tissue repair and regeneration. The company offers fibrin microbeads for isolation and implantation of autologous stem cells, and haptotactic peptide coatings for developing skin wound dressing and for improving drug delivery into cells.

Contact Information

Ownership Status
Financing Status
Formerly VC-backed
Primary Industry
Other Industries
Other Pharmaceuticals and Biotechnology
Forticell Bioscience
Primary Office
  • Post Office Box 12275
  • Hadassah Ein Kerem
  • Jerusalem 91121
  • Israel
+972 00-000-0000
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

HAPTO Biotech (Israel) Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. Merger/Acquisition 14-Apr-2006 Completed Generating Revenue
1. Early Stage VC 25-Aug-2000 Completed Startup
To view HAPTO Biotech (Israel)’s complete valuation and funding history, request access »

HAPTO Biotech (Israel) Executive Team (1)

Name Title Board Seat Contact Info
Raphael Hofstein Ph.D Managing Director
To view HAPTO Biotech (Israel)’s complete executive team members history, request access »

HAPTO Biotech (Israel) Former Investors (2)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Mediseed Venture Capital Minority 000 0000 000000 0
Migdal Haemek Technology Center Accelerator/Incubator Minority 000 0000 000000 0
To view HAPTO Biotech (Israel)’s complete investors history, request access »